Clinical significance of genetic diagnosis of free cancer cells in peritoneal lavage fluids obtained from gastric cancer surgery: Results from a prospective multicenter clinical trial.

Clinical significance of genetic diagnosis of free cancer cells in peritoneal lavage fluids obtained from gastric cancer surgery: Results from a prospective multicenter clinical trial. - Clinical significance of genetic diagnosis with peritoneal lavage fluids.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007684

Enrollment

140

Registered

2012-04-09

Start date

2007-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinically serosal-invaded gastric cancer

Interventions

Genetic diagnosis was introduced for peritoneal lavage diagnosis.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, Histological confirmation of gastric cancer 2, Existence of serosa-invading tumor as a preoperative diagnosis 3, The absence of non-curative factors 4, No severe medical conditions

Exclusion criteria

Exclusion criteria: 1, No other active cancer 2, No active hemorrhage/bleeding

Design outcomes

Primary

Measure	Time frame
Patient survival and peritoneal lavage genetic diagnosis	—

Secondary

Measure	Time frame
Peritoneal recurrence-free survival and genetic diagnosis	—

Countries

Japan

Contacts

Public ContactYoshiyuki Fujiwara

Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Surgery

+81-6-6972-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026